GRANULES INDIA
Back to Income Statement
|
GRANULES INDIA Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹517 Cr | ₹413 Cr | ₹5,495 Cr | ₹335 Cr | ₹236 Cr |
What is the latest Consolidated Net Profit of GRANULES INDIA ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹517 Cr |
Mar2023 | ₹413 Cr |
Mar2022 | ₹5,495 Cr |
Mar2021 | ₹335 Cr |
Mar2020 | ₹236 Cr |
How is Consolidated Net Profit of GRANULES INDIA Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹517 Cr | 25.16 | |
Mar2023 | ₹413 Cr | -92.49 | |
Mar2022 | ₹5,495 Cr | 1,538.23 | |
Mar2021 | ₹335 Cr | 41.87 | |
Mar2020 | ₹236 Cr | - |
Compare Consolidated Net Profit of peers of GRANULES INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GRANULES INDIA | ₹12,120.3 Cr | 5.4% | 0.4% | -4.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,091.0 Cr | 2.3% | 3.2% | 9.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,302.0 Cr | -0.2% | 4.5% | 49.6% | Stock Analytics | |
CIPLA | ₹119,038.0 Cr | -0.2% | -2% | -1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹117,170.0 Cr | 3.7% | 6.5% | 16.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,061.0 Cr | -0% | -4.6% | -6.2% | Stock Analytics |
GRANULES INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GRANULES INDIA | 5.4% |
0.4% |
-4.4% |
SENSEX | -1.1% |
1% |
3.4% |
You may also like the below Video Courses